The Gross Margin of Reyon Pharmaceutical Co Ltd (102460.KS) is 49.08%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 49.08% |
| 2023-12-31 | 52.23% |
| 2022-12-31 | 53.06% |
| 2021-12-31 | 55.63% |
| 2020-12-31 | 55.82% |
| 2019-12-31 | 56.45% |
| 2018-12-31 | 55.71% |
| 2017-12-31 | 57.54% |
| 2016-12-31 | 57.71% |
| 2015-12-31 | 58.50% |